Real-time enrollment status for this her2-positive cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 1:53 PM UTC
| NCT Number | NCT05150691 |
| Recruiting Status | Recruiting |
| Condition | HER2-positive Cancer |
| Phase | PHASE1 |
| Target Enrollment | 796 participants |
| Active Locations | 35 sites in the US |
| Sponsor | DualityBio Inc. |
| Last Updated on CT.gov | August 27, 2026 (Aug 27, 2026) |
As of October 15, 2026: Clinical trial NCT05150691 is currently recruiting participants. This phase1 study for her2-positive cancer is actively seeking new participants at 35 locations across the United States. The study is sponsored by DualityBio Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05150691 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05150691 was last updated Aug 27, 2026 (August 27, 2026). HelloStudys verifies this status automatically.